Keywords: Sosei, SD118, Beijing Tide Pharma, NeuroDiscovery, Neuropathic pain

Sosei assigns SD118 assets to Beijing Tide Pharma

Article | 14 August 2012

Japanese biopharma firm Sosei Group Corp (TSE Mothers Index: 4565) announced that its wholly-owned Japanese subsidiary, Sosei Co has assigned its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sosei

Beijing Tide Pharmaceutical

Go to company listing

Related Drugs

SD118

Go to drug listing